Your browser doesn't support javascript.
loading
Effects of CYP2C19 genetic polymorphisms on the pharmacokinetics of lacosamide in Korean patients with epilepsy.
Ahn, Seon-Jae; Oh, Jaeseong; Kim, Do-Yong; Son, Hyoshin; Hwang, Sungeun; Shin, Hye-Rim; Kim, Eun Young; Lee, Han Sang; Lee, Woo-Jin; Moon, Jangsup; Lee, Soon-Tae; Jung, Keun-Hwa; Park, Kyung-Il; Jung, Ki-Young; Lee, SeungHwan; Yu, Kyung-Sang; Chu, Kon; Lee, Sang Kun.
Afiliação
  • Ahn SJ; Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
  • Oh J; Hospital Medicine Center, Seoul National University Hospital, Seoul, South Korea.
  • Kim DY; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
  • Son H; Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
  • Hwang S; Hospital Medicine Center, Seoul National University Hospital, Seoul, South Korea.
  • Shin HR; Department of Neurosurgery, Seoul National University Hospital, Seoul, South Korea.
  • Kim EY; Department of Neurology, Ewha Womans University Mokdong Hospital, Seoul, South Korea.
  • Lee HS; Department of Neurology, Dankook University Hospital, Cheonan, South Korea.
  • Lee WJ; Department of Neurology, Chungnam National University Sejong Hospital, Sejong, South Korea.
  • Moon J; Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
  • Lee ST; Hospital Medicine Center, Seoul National University Hospital, Seoul, South Korea.
  • Jung KH; Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
  • Park KI; Department of Neurology, Seoul National University Bundang Hospital, Seongnam-si, South Korea.
  • Jung KY; Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
  • Lee S; Department of Genomic Medicine, Seoul National University Hospital, Seoul, South Korea.
  • Yu KS; Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
  • Chu K; Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
  • Lee SK; Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
Epilepsia ; 63(11): 2958-2969, 2022 11.
Article em En | MEDLINE | ID: mdl-36039802
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epilepsia / Citocromo P-450 CYP2C19 / Lacosamida / Anticonvulsivantes Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Epilepsia Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Coréia do Sul
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epilepsia / Citocromo P-450 CYP2C19 / Lacosamida / Anticonvulsivantes Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Epilepsia Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Coréia do Sul